Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Nanobiotix
  6. News
  7. Sector news
    NANO   FR0011341205

NANOBIOTIX

(NANO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Sector news Other Biotechnology & Medical Research
01/28SVB Leerink Adjusts Moderna's Price Target to $85 From $86, Maintains Underperform Rati..
MT
01/28AlphaValue/Baader Europe Lifts Price Target on Lonza Group, Maintains Add Recommendatio..
MT
01/28Moderna, Pfizer Boosters Provide High Level of Protection Against Omicron, UK Health Se..
MT
01/27Lonza to Manufacture HaemaLogiX's Myeloma Drug Candidate KappaMab
MT
01/27Pfizer/BioNTech, Moderna COVID-19 Booster Shots Provide Protection Against Death from O..
MT
01/27HaemaLogiX Pty. Ltd. and Lonza Collaborates to Manufacture Kappamab, A Multiple Myeloma..
CI
01/27Moderna, IAVI Say Clinical Trial of Experimental HIV Vaccine Antigens is Underway
MT
01/26Pfizer-BioNTech, Moderna COVID-19 Jabs Shown Safe For Women Undergoing IVF in Study
MT
01/26Moderna Launches Mid-Stage Study of Omicron-Specific Booster Jab
MT
01/26Moderna starts trial for Omicron-specific booster shot
RE
01/26Moderna starts trial testing Omicron-specific booster shot
RE
01/26Moderna Starts Clinical Trial Of Booster Shot Targeting Omicron Covid Variant - CNBC
RE
01/26IQVIA Holdings Inc. Appoints Sheila A. Stamps to Board of Directors
CI
01/26Moderna's Shares Rise After Deutsche Bank Upgrade
MT
01/26Lonza Group Ltd. Appoints Marion Helmes as Independent Member of the Board of Directors..
CI
01/26Deutsche Bank Upgrades Moderna to Hold From Sell, Adjusts Price Target to $175 From $20..
MT
01/26Lonza Group to Seek Acquisitions
CI
01/26INSIDER SELL : Moderna
MT
01/26ANALYST RECOMMENDATIONS : Alphabet, IBM, Meta, Moderna, Netflix...
01/26COVID-19 Severity Appears Lower With Omicron, But High Hospitalization Volume Could Str..
MT
01/26Lonza Offers Rosy Outlook After Divisional Growth Leads 2021 Sales To Beat Market Expec..
MT
01/26Lonza Posts Higher 2021 Sales; Confirms Mid-Term Targets
DJ
01/26Lonza's full-year core EBITDA up 20.7% on vaccine demand
RE
01/26Lonza's FY21 Profit Triples After Strong Sales Growth in All Divisions
MT
01/26Lonza Group Ltd Reports Earnings Results for the Full Year Ended December 31, 2021
CI
01/26Lonza Group Ltd. Announces Sales Guidance for the Full-Year 2022
CI
01/26Lonza Group Ltd. Announces Board Changes
CI
01/26Lonza Group Ltd. Proposes Dividend for 2021
CI
01/25Lonza Gets US Injunction in Patent Infringement Case Against Adva Biotechnology
MT
01/25US Labor Department's OSHA Revokes COVID-19 Vaccination Order for Large Employers
MT
01/25EMA Says Clinical Data Published Supporting Extension Of Indication For Spikevax To Inc..
RE
01/25AlphaValue/Baader Europe Lowers Price Target on Lonza Group, Upgrades Recommendation to..
MT
01/25Seagen Canada Announces Availability of PADCEV® to Treat Advanced Bladder Cancer
CI
01/25J&J expects jump in COVID vaccine sales in 2022, eyes device deals
RE
01/25Germany to receive 3.8 mln doses of Novavax's new COVID vaccine in Q1
RE
01/24Leslie Wims Morris Joins IQVIA Board of Directors
CI
01/24Chile to purchase 2 million Moderna COVID-19 vaccine doses
RE
01/24INSIDER SELL : Moderna
MT
01/21Moderna's Valuation Has Come 'Back to Earth,' Become More Reasonable, BofA Securities S..
MT
01/21UBS Initiates Coverage on Moderna With Neutral Rating, $221 Price Target
MT
01/21BofA Securities Upgrades Moderna to Neutral From Underperform, Adjusts Price Target to ..
MT
01/20Moderna says aims to name 'country of choice' for COVID vaccine production in Africa so..
RE
01/20EMA Says Spikevax Product Information To Be Updated To Include Paraesthesia As Rare Sid..
RE
01/19Prior COVID infection more protective than vaccination during Delta surge, U.S. study f..
RE
01/19Valneva Shares Suffer as Coronavirus Vaccine Seen Arriving Too Late
DJ
01/18Lonza Signs Biologics Development Deal With Forbion, BioGeneration Ventures
MT
01/18US Stocks Slump as Treasury Yields Hit 2-Year High, Goldman Sachs Weighs on Financials
MT
01/18Seagen Inc. Announces Data from Phase I Clinical Trial Combining SEA-CD40
CI
01/18US Stocks Start Week Lower as Treasury Yields Hit 2-Year High, Goldman Sachs Weighs on ..
MT
01/18Morgan Stanley Adjusts Seagen Price Target to $178 From $181, Maintains Equalweight Rat..
MT
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on NANOBIOTIX
03/30/22